ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $315,413 | -46.1% | 19,410 | -38.7% | 0.04% | -40.5% |
Q1 2024 | $585,282 | -1.5% | 31,654 | +66.7% | 0.07% | -36.2% |
Q4 2023 | $594,420 | +578.8% | 18,985 | +351.8% | 0.12% | +364.0% |
Q3 2023 | $87,570 | +71.5% | 4,202 | +97.1% | 0.02% | +56.2% |
Q2 2023 | $51,061 | +23.4% | 2,132 | -3.0% | 0.02% | +14.3% |
Q1 2023 | $41,366 | +58.0% | 2,198 | +33.6% | 0.01% | +27.3% |
Q4 2022 | $26,188 | +4.8% | 1,645 | +8.6% | 0.01% | 0.0% |
Q3 2022 | $25,000 | – | 1,515 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |